Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis

RATIONAL: Lung cancer is the most common tumor worldwide, with the highest mortality rate and second highest incidence. Immunotherapy is one of the most important treatments for lung adenocarcinoma (LUAD); however, it has relatively low response rate and high incidence of adverse events. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xi-Yang, Xiong, Yan-Lu, Zhao, Ya-Bo, Yang, Jie, Shi, An-Ping, Zheng, Kai-Fu, Liu, Yu-Jian, Shu, Chen, Jiang, Tao, Ma, Nan, Zhao, Jin-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577086/
https://www.ncbi.nlm.nih.gov/pubmed/36268014
http://dx.doi.org/10.3389/fimmu.2022.1014053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577086/
https://www.ncbi.nlm.nih.gov/pubmed/36268014
http://dx.doi.org/10.3389/fimmu.2022.1014053

Ejemplares similares